Green Thumb Industries: A Profitable Cannabis Leader Poised for a Rescheduling-Driven Revaluation

Related Articles

Trulieve's CEO Sells into Strength: A Calculated Move Amid Cannabis Rescheduling's Windfall

2 months ago

Sigma Lithium's Production Beat Defies Market Surplus, Signaling a Green Growth Leader

2 months ago

Is Dycom Industries Poised for a Broadband Boom

4 months ago

Is the Energy Sector the New Market Leader in 2026

5 months ago

Category

You may also like

Stock News•3 weeks ago

Green Thumb Opens Its 13th Nevada Location, RISE Dispensary Sparks, on August 18

Green Thumb Industries opened its 13th Nevada retail location, RISE Dispensary Sparks, on August 18, expanding its footprint in the state's cannabis market.

RISE

Share

Stock News•1 months ago

GRNJ: Underdog ETF Is Beating The Market YTD

GRNJ ETF outperformed VOT and VOO year-to-date, driven by its two-theme selection process targeting AI infrastructure and secular trends, despite a 0.75% expense ratio.

GRNJ

Share

Stock News•2 months ago

MSOS: Adult-Use Rescheduling The Next Catalyst For Cannabis Stocks

The AdvisorShares Pure US Cannabis ETF (MSOS) is rated a buy, driven by regulatory progress. Rescheduling medical cannabis to Schedule III reduces tax burdens, improving cash flows and cost of capital...

MSOS

Share